Adjunctive Game Intervention for Anhedonia in MDD Patients
Game Intervention as Adjunct Therapy for Anhedonia in Patients With Major Depressive Disorder
1 other identifier
interventional
50
1 country
1
Brief Summary
This is a pilot study using game intervention as an adjuvant treatment, to evaluate the effect of the video game on anhedonia and associated functional change of brain in patients with depression. Participants will be randomized to Experimental group receiving a 8-week treatment of antidepressant drugs and game intervention, or Control group receiving a 8-week treatment of antidepressant drugs. Magnetic resonance imaging scanning and assessment of clinical characteristics and cognitive function were conducted before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2021
CompletedFirst Posted
Study publicly available on registry
July 26, 2021
CompletedStudy Start
First participant enrolled
September 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedAugust 21, 2024
August 1, 2024
1.3 years
July 13, 2021
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Snaith-Hamilton-Pleasure Scale (SHAPES)
Pre-post assessment of anhedonia via the Snaith-Hamilton-Pleasure Scale (SHAPES). Raw score range is 14-56. A higher score indicates a worse outcome.
From baseline to 8 weeks
Temporal Experience of Pleasure Scale (TEPS)
Pre-post assessment of anhedonia via the Temporal Experience of Pleasure Scale (TEPS). Raw score range is 20-120. A lower score indicates a worse outcome.
From baseline to 8 weeks
Hamilton Depression Rating scale (HAMD)
Pre-post assessment of depressive symptoms via Hamilton Depression Rating scale (HAMD). Raw score range is 0-52. Higher scores indicate more severe depression.
From baseline to 8 weeks
Secondary Outcomes (5)
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
From baseline to 8 weeks
The Stroop test
From baseline to 8 weeks
Wisconsin Card Sorting Test (WCST)
From baseline to 8 weeks
Rumination Responses Scale
From baseline to 8 weeks
Magnetic Resonance Imaging data
From baseline to 8 weeks
Study Arms (2)
Escitalopram + game intervention
EXPERIMENTALEscitalopram treatment and game intervention are given in combinations for 8 weeks.
Escitalopram
ACTIVE COMPARATOREscitalopram treatment for 8 weeks
Interventions
Selective serotonin reuptake inhibitors (SSRI) were most commonly used first line pharmacotherapy for depression.
Participants will be instructed to play the commercial video game for about 30-60 minutes at least three times per week.
Eligibility Criteria
You may qualify if:
- a diagnosis of Major Depressive Disorder according to DSM IV or V and validated via Mini International Neuropsychiatric Interview (M.I.N.I.)
- right handedness
- capability of understanding and finishing self-rating scales
- capability of providing informed consent
You may not qualify if:
- any other major psychiatric disorders following DSM-5 diagnostic criteria
- neurological diseases
- a history of drug abuse
- suicidal risk
- pregnancy
- any contraindication for brain MRI scan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Xiangya Hospital of Central South University
Changsha, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenbin Guo
Central South University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry Department of Psychiatry of the Second Xiangya Hospital, Central South University
Study Record Dates
First Submitted
July 13, 2021
First Posted
July 26, 2021
Study Start
September 9, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
August 21, 2024
Record last verified: 2024-08